"Insight Clinical Trials is a 100% dedicated clinical research facility in Beachwood, Ohio. Our mission is to find more treatment options for patients with neurological disorders and mental illnesses. We specialize in conducting clinical research trials with the newest and most promising treatment options for neurological disorders such as depression, ADHD, Alzheimer’s disease as well as many other psychiatric conditions. All of our services are offered at no cost to patients or families and we do not require insurance. We take part in dozens of research studies each year to learn more about investigational medications that are not yet available to the public. With your help, new treatments can help more people locally and around the world."

During the past decade, Insight Clinical Trials LLC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Insight Clinical Trials LLC" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Biogen" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Insight Clinical Trials LLC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Insight Clinical Trials LLC" are "Alzheimer's Disease" (8 trials), "Alzheimer Disease" (5 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials) and "Dementia of Alzheimer Type" (1 trials). Many other conditions were trialed in "Insight Clinical Trials LLC" in a lesser frequency.

Most popular intervention types in "Insight Clinical Trials LLC" are "Drug" (20 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "AVP-786" (2 trials), "Pimavanserin" (2 trials), "Solanezumab" (2 trials) and "AC-1204" (1 trials). Other intervention names were less common.

The vast majority of trials in "Insight Clinical Trials LLC" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Insight Clinical Trials LLC". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Insight Clinical Trials LLC, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Insight Clinical Trials LLC, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".